Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early combination therapy versus monotherapy in newly diagnosed adult focal epilepsy (valproate + carbamazepine)
ChiCTR2100048530Phase 4Not yet recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-sen University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in epilepsy comparing Intervention arm: valproate + carbamazepine with Control arm: carbamazepine + valproate-placebo (2 arms). Primary endpoint: Seizure free rate. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
valproic acidcarbamazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2100048530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048530.